Recent preclinical and clinical studies have indicated that the galanin peptide family may
regulate glucose metabolism and alleviate insulin resistance, which diminishes the …

The rapid increase in the prevalence of overweight and obesity is becoming an important
health problem. Overweight and obesity may cause several metabolic complications …

Metabolic syndrome (MetS) is defined as abdominal central obesity, atherogenic
dyslipidemia, insulin resistance, glucose intolerance and hypertension. The rapid increasing …

Although recent results of our and other studies have showed that galanin (GAL) is an
antidiabetic and anti-inflammatory neuropeptide, the molecular mechanism how central GAL …

Galanin, a brain and pancreatic peptide with three receptor subtypes (GALR1, GALR2, and
GALR3), is hypothesized to participate in energy homeostasis and glucoregulation …

The hypothalamic neuropeptides modulate physiological activity via G protein‐coupled
receptors (GPCRs). Galanin‐like peptide (GALP) is a 60 amino acid neuropeptide that was …

Seeing that galanin increases animal body weight on the conditions of inhibiting insulin
secretion and animals with metabolic disorder of galanin easily suffer from diabetes, we …

Objective Decreasing duodenal contraction is now considered as a major focus for the
treatment of type 2 diabetes. Therefore, identifying bioactive molecules able to target the …

Purpose Our and other's studies showed that administration of neuropeptide galanin may
mitigate insulin resistance via promoting glucose transporter 4 (GLUT4) expression and …

The diabetic heart is characterized by its impaired ability to utilize glucose. Therapeutic
interventions focusing on reducing insulin resistance and enhancing glucose uptake may …